Sign up to get your rebate amount up to $50 per treatment, when you are treated with XTRAC a minimum of 8 times in 42 days or less.
WHY CHOOSE XTRAC?
CONVENIENT AND EFFECTIVE
Unlike conventional light therapies, the XTRAC excimer laser delivers a highly targeted therapeutic beam of UVB light to areas of the skin affected by psoriasis, vitiligo and atopic dermatitis without harming the surrounding skin so you can LIVE CLEAR. LIVE FREE.
In clinical trials for psoriasis, most people saw at least 75% improvement and even 95% clearance in just 4 weeks.*
Virtually No Side Effects
And pain free
Typically several months free of symptoms with some staying clear up to 1 year.*
No Messy Creams
Relief without messy creams and daily skin care regimen
XTRAC has been cleared by the FDA and cited in over 45 clinical studies and research programs
Covered by most major insurance companies
*Individual results may vary. Talk to your doctor about a treatment protocol that is right for you.
WHAT PATIENTS SAY
“What my patients love most about the XTRAC Treatments is that it’s safe, it’s FDA cleared, and they’re seeing results very quickly.”
Ashley H. XTRAC Clinical Specialist
“The thing that attracted me to the XTRAC was the fact that it was not invasive, no side effects, and so very effective. It was a total match for my lifestyle.”
Diana K. Active Walker, Active Grandmother
“It’s totally safe, there’s no side effects, it’s FDA thumbs up. If anyone’s out there watching this and wondering if it would work I would just say give it a try…”
Kai E. XTRAC Patient
“In my case, the psoriasis being on my scalp, it was really great that XTRAC could really get in there through the hair where creams and things just kinda don’t…”
Tonette R. XTRAC Patient
XTRAC has been cleared by the FDA and cited in over 45 clinical studies and research programs with findings published in peer-reviewed medical journals around the world. XTRAC is also endorsed by the National Psoriasis Foundation and the technology is part of the approved clinical protocols recommended by the American Academy of Dermatology.